slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
61.700 KRW | -0,48% | +0,16% | -14,31% |
Vakgebied
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Vaccine/Biopharmaceuticals
100,0
%
| 456 726 | 100,0 % | 369 506 | 100,0 % | -19,10% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
America
50,3
%
| 217 834 | 47,7 % | 185 961 | 50,3 % | -14,63% |
South Korea
42,8
%
| 224 157 | 49,1 % | 158 217 | 42,8 % | -29,42% |
Europe
5,7
%
| 13 778 | 3,0 % | 21 202 | 5,7 % | +53,88% |
Asia
1,1
%
| 651 | 0,1 % | 3 893 | 1,1 % | +497,76% |
Middle East
0,1
%
| 305 | 0,1 % | 232 | 0,1 % | -24,07% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jae-Yong An
CEO | Chief Executive Officer | 56 | - |
Yong-Sung Choi
DFI | Director of Finance/CFO | 51 | - |
Sally Choe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jong-Gu Park
CTO | Chief Tech/Sci/R&D Officer | 59 | - |
Hun Kim
CTO | Chief Tech/Sci/R&D Officer | 57 | 01-01-18 |
Young-Joo Park
IRC | Investor Relations Contact | 54 | - |
Harry Kleanthous
PRN | Corporate Officer/Principal | - | 21-10-22 |
Ji-Hyun Yoo
LAW | General Counsel | 46 | - |
Su-Ahn Yoo
SAM | Sales & Marketing | 51 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Choi
BRD | Director/Board Member | 60 | - |
Chang-Jin Moon
BRD | Director/Board Member | 71 | - |
Jae-Yong An
CEO | Chief Executive Officer | 56 | - |
Mi-Jin Cho
BRD | Director/Board Member | 61 | - |
Gwang-Hyun Jeon
BRD | Director/Board Member | 59 | - |
Hun Kim
CTO | Chief Tech/Sci/R&D Officer | 57 | 01-01-18 |
Ik-Hwan Kwon
BRD | Director/Board Member | 57 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 76 827 750 | 24 160 559 ( 31,45 %) | 0 | 31,45 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
NOVAVAX, INC. 5.47% | 6 500 000 | 5.47% | 32 110 000 $ |
Bedrijfsgegevens
SK bioscience Co., Ltd.
310 Pangyo-ro Bundang-gu
13494, Seongnam-si
+82 2 2008 2200
http://www.skbioscience.co.krSector
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,31% | 3,53 mld. | |
+0,44% | 90,27 mld. | |
+9,61% | 44,05 mld. | |
-16,67% | 31,45 mld. | |
+44,99% | 23,35 mld. | |
-9,41% | 16,72 mld. | |
-25,92% | 15,09 mld. | |
-9,27% | 12,82 mld. | |
-7,57% | 11,95 mld. | |
+0,07% | 8,71 mld. |
- Beurs
- Aandelen
- Aandeel SK bioscience Co.,Ltd. - Korea S.E.
- Onderneming SK bioscience Co.,Ltd.